Hanall Biopharma’s global expansion chosen as one of ’10 Most Outstanding Scientific Technology News’
Hanall Biopharma’ large biotechnology export was selected as one of the ’10 Most Outstanding Scientific Technology News of The Year’ by the Korean Federation of Science and Technology Societies(KOFST).
Last December, Hanall Biopharma has succeeded in exporting its technology license of HL161, a ...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.